应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PCVX Vaxcyte, Inc.
休市中 10-02 16:00:00 EDT
56.48
+0.43
+0.77%
盘后
56.48
+0.00
0.00%
19:49 EDT
最高
57.00
最低
55.84
成交量
239.96万
今开
56.76
昨收
56.05
日振幅
2.07%
总市值
84.05亿
流通市值
76.81亿
总股本
1.49亿
成交额
1.35亿
换手率
1.76%
流通股本
1.36亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Vaxcyte任命首席医疗官及首席法务官,并收窄Vax-31 Opus-1关键数据发布预期
美股速递 · 09-04
Vaxcyte任命首席医疗官及首席法务官,并收窄Vax-31 Opus-1关键数据发布预期
Vaxcyte启动Vax-a1一期临床研究,首位健康成人受试者完成给药
美股速递 · 06-03
Vaxcyte启动Vax-a1一期临床研究,首位健康成人受试者完成给药
Vaxcyte, Inc.盘中异动 快速拉升5.10%
市场透视 · 2025-03-06
Vaxcyte, Inc.盘中异动 快速拉升5.10%
Vaxcyte, Inc.2024财年实现净利润-4.64亿美元,同比减少15.42%
市场透视 · 2025-03-02
Vaxcyte, Inc.2024财年实现净利润-4.64亿美元,同比减少15.42%
Vaxcyte, Inc.盘中异动 下午盘股价大跌5.08%
市场透视 · 2025-02-28
Vaxcyte, Inc.盘中异动 下午盘股价大跌5.08%
Vaxcyte, Inc.盘中异动 早盘股价大涨5.00%报90.84美元
市场透视 · 2025-02-06
Vaxcyte, Inc.盘中异动 早盘股价大涨5.00%报90.84美元
特朗普2.0时代即将开启,投资机会如何掘金?
招商基金 · 2025-01-20
特朗普2.0时代即将开启,投资机会如何掘金?
Vaxcyte, Inc.盘中异动 急速拉升5.23%报82.23美元
市场透视 · 2025-01-15
Vaxcyte, Inc.盘中异动 急速拉升5.23%报82.23美元
Vaxcyte, Inc.盘中异动 急速下跌5.02%
市场透视 · 2025-01-09
Vaxcyte, Inc.盘中异动 急速下跌5.02%
Vaxcyte, Inc.盘中异动 下午盘快速下跌5.01%报81.48美元
市场透视 · 2024-12-28
Vaxcyte, Inc.盘中异动 下午盘快速下跌5.01%报81.48美元
Vaxcyte, Inc.盘中异动 临近收盘快速跳水5.10%报85.28美元
市场透视 · 2024-12-19
Vaxcyte, Inc.盘中异动 临近收盘快速跳水5.10%报85.28美元
Vaxcyte, Inc.盘中异动 下午盘股价大涨5.06%
市场透视 · 2024-11-22
Vaxcyte, Inc.盘中异动 下午盘股价大涨5.06%
Vaxcyte, Inc.涨0.89% 股价突破100美元大关
市场透视 · 2024-11-13
Vaxcyte, Inc.涨0.89% 股价突破100美元大关
Vaxcyte, Inc.2024财年第三财季实现净利润-1.03亿美元,同比减少11.16%
市场透视 · 2024-11-10
Vaxcyte, Inc.2024财年第三财季实现净利润-1.03亿美元,同比减少11.16%
Vaxcyte, Inc.盘中异动 股价大跌5.26%
市场透视 · 2024-10-30
Vaxcyte, Inc.盘中异动 股价大跌5.26%
加载更多
公司概况
公司名称:
Vaxcyte, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Vaxcyte, Inc.于2013年11月27日在特拉华州注册成立。该公司是一家下一代疫苗公司,旨在通过开发预防或治疗全球某些最常见和致命的传染病的新型疫苗来改善全球健康状况。他们的无细胞蛋白质合成平台使他们能够设计和生产蛋白质载体和抗原,这是疫苗的关键组成部分。
发行价格:
--
{"stockData":{"symbol":"PCVX","market":"US","secType":"STK","nameCN":"Vaxcyte, Inc.","latestPrice":56.48,"timestamp":1790971200000,"preClose":56.05,"halted":0,"volume":2399638,"hourTrading":{"tag":"盘后","latestPrice":56.48,"preClose":56.48,"latestTime":"19:49 EDT","volume":46379,"amount":2618836.546,"timestamp":1790984943698,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.007671721677074036,"floatShares":136000000,"shares":148805278,"eps":-7.649608,"marketStatus":"休市中","change":0.43,"latestTime":"10-02 16:00:00 EDT","open":56.76,"high":57,"low":55.84,"amount":135095333.646532,"amplitude":0.020696,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.649608,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":56.05,"preHourTrading":{"tag":"盘前","latestPrice":56.05,"preClose":56.05,"latestTime":"08:46 EDT","volume":2,"amount":112.1,"timestamp":1790945213855,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":56.48,"preClose":56.48,"latestTime":"19:49 EDT","volume":46379,"amount":2618836.546,"timestamp":1790984943698,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.7227063835831915,"optionData":{"bulkOrders":[{"symbol":"PCVX","call":true,"expireDate":1797570000000,"strike":"90.0","timestamp":1790956465931,"price":2,"volume":18070,"amount":3614000,"type":"+"}]},"impliedVol":1.1148,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/PCVX","defaultTab":"news","newsList":[{"id":"1142006324","title":"Vaxcyte任命首席医疗官及首席法务官,并收窄Vax-31 Opus-1关键数据发布预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1142006324","media":"美股速递","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142006324?lang=zh_cn&edition=full","pubTime":"2026-09-04 04:06","pubTimestamp":1788465978,"startTime":"0","endTime":"0","summary":"Vaxcyte宣布了两项重要人事任命,同时进一步明确了其核心候选疫苗Vax-31的Opus-1临床研究关键数据发布的时间窗口。在领导层补强的同时,Vaxcyte也对其Vax-31 Opus-1研究的顶线数据揭晓预期进行了收窄,给出了更为具体的时间指引。市场分析人士认为,Vaxcyte此番人事布局与预期管理并行,旨在为其核心资产的潜在商业化与监管互动铺平道路。随着Vax-31关键数据的临近,公司高层的稳定与决策效率将变得至关重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","LU0053671581.USD","BK4139","PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155910968","title":"Vaxcyte启动Vax-a1一期临床研究,首位健康成人受试者完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1155910968","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155910968?lang=zh_cn&edition=full","pubTime":"2026-06-03 04:06","pubTimestamp":1780430800,"startTime":"0","endTime":"0","summary":"Vaxcyte, Inc. 宣布,其旨在预防A组链球菌所致疾病的研究性疫苗Vax-a1,已在一期临床试验中为首位健康成人受试者完成给药。该研究旨在评估Vax-a1在健康成年人群中的安全性、耐受性和免疫原性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0053671581.USD","PCVX","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517346929","title":"Vaxcyte, Inc.盘中异动 快速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517346929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517346929?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:45","pubTimestamp":1741207533,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时45分,Vaxcyte, Inc.股票出现波动,股价快速上涨5.10%。Vaxcyte, Inc.股票所在的生物技术行业中,整体涨幅为1.97%。Vaxcyte, Inc.公司简介:Vaxcyte Inc 是一家疫苗公司,致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者,从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306044533a2612eba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306044533a2612eba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX","BK4139","IE0009354923.USD","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516552206","title":"Vaxcyte, Inc.2024财年实现净利润-4.64亿美元,同比减少15.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516552206?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:01","pubTimestamp":1740844868,"startTime":"0","endTime":"0","summary":"3月2日,Vaxcyte, Inc.公布财报,公告显示公司2024财年净利润为-4.64亿美元,同比减少15.42%;其中营业收入为0.00美元,每股基本收益为-3.80美元。从资产负债表来看,Vaxcyte, Inc.总负债2.27亿美元,其中短期债务5.89百万美元,资产负债比为15.57,流动比率为12.78。机构评级:截至2025年3月2日,当前有9家机构对Vaxcyte, Inc.目标价做出预测,其中目标均价为150.22美元,其中最低目标价为135.00美元,最高目标价为163.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000148abe2c5d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000148abe2c5d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514333298","title":"Vaxcyte, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514333298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514333298?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:07","pubTimestamp":1740686870,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时07分,Vaxcyte, Inc.股票出现波动,股价快速下跌5.08%。Vaxcyte, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,Pepgen Inc.、Ibio, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大,Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃,换手率分别为1919.08%、338.83%、188.69%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation,振幅分别为86.14%、67.32%、55.84%。Vaxcyte, Inc.公司简介:Vaxcyte Inc 是一家疫苗公司,致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者,从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228040750a256c504&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228040750a256c504&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","IE0009354923.USD","PCVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509350942","title":"Vaxcyte, Inc.盘中异动 早盘股价大涨5.00%报90.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509350942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509350942?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:18","pubTimestamp":1738772301,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时18分,Vaxcyte, Inc.股票出现波动,股价急速拉升5.00%。截至发稿,该股报90.84美元/股,成交量15.0673万股,换手率0.12%,振幅3.92%。Vaxcyte, Inc.股票所在的生物技术行业中,整体涨幅为1.36%。Vaxcyte, Inc.公司简介:Vaxcyte Inc 是一家疫苗公司,致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者,从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206001821987b8e87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206001821987b8e87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX","BK4139","LU0053671581.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504449484","title":"特朗普2.0时代即将开启,投资机会如何掘金?","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启,有哪些投资机会可以布局?值得一提的是,科技股在特朗普任期内表现尤为突出,成为推动美股上涨的主要力量。在特朗普第一个任期内,美元整体表现相对弱势。4年任期内,美元指数累计下跌了10.53%。而纵观全球市场,在特朗普上一任期内,恒生科技指数涨幅超过147%,表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OLED","ENTG","HST","AVGO","BMRN","PNFP","HON","ILMN","CME","TTEK","NICE","HQY","NTAP","PSQ","LKQ","ROST","MDLZ","CDW","GMAB",".IXIC","TSCO","GNTX","LU1815336091.USD","MNST","BK4550","APA","JKHY","MRNA","ALNY","DKNG","ROKU","FSLR","RGLD","NQmain","TER","DPZ","BK4581","CDNS","CASY","EBAY","KDP","AMD","WWD","AUR","WTFC","LOGI","RGEN","MRVL","SRPT","ALAB","CFLT","HSIC","DOCU","ERIE","LNT","EXE","FOX","NDSN","SFM","LI","NDAQ","INCY","NVDA","CINF","NTRS","QLD","FOXA","STLD","NFLX","MNQmain","BRKR","AAL","DLTR","DDOG","HBAN","ROIV","AZN","EQIX","WBA","GEN","GILD","SWKS","TLN","ULTA","ROP","CHDN","TTWO","DSGX","MANH","SQQQ","CTAS","OTEX","PAA","NTRA","NVIW.SI","COIN","MSFT","ARM","FYBR","SBAC","ODFL","RPRX","ESLT","EA","CHRW","TPG","ICLR","LSTR","ALGN","SEIC","TQQQ","FWONK","PCVX","CCEP","NVMI","BPMC","FRPT","TRMB","PCAR","INSM","FSV","QRVO","RYAAY","MDB","LU0053671581.USD","CSGP","CWST","CSWI","PDD","FTAI","ADBE","AEP","FAST","HOOD","MARA","QID","AFRM","ADSK","REG","BKR","SMCI","BSY","NWSA","GLPI","BK4593","COKE","GTLB","MPWR","CSCO","MCHP","SOFI","USJW.SI","ADI","PARA","FFIV","RIVN","TSYW.SI","CHKP","MIDD","LPLA","EVRG","TROW","NTES","AMGN","COO","META","TXN","ON","TTD","GOOGL","COST","AAPL","BK4561","HOLX","MEDP","CPB","ITCI","ONC","SNPS","FTNT","PCTY","BPOP","BK4086","CZR","NXPI","IDXX","CEG","RKLB","LULU","LSCC","GEHC","PFG","AXON","BIIB","MTSI","ISRG","LAMR","AMZN","PAYX","AKAM","MNDY","POOL","EWBC","BK4588","HLNE","AGNC","TW","AAON","MKTX","LU2065731478.USD","QCOM","QXO","TMUS","CSX","BK4585","TCOM","CRWD","WYNN","CHRD","AMAT","LNW","CBSH","TEAM","OKTA","BK4534","EXAS","JBHT","LU0757428866.USD","SBUX","FCNCA","PLTR","EXPE","BKNG","PODD","CHTR","RADX","SIRI","ENPH","ZS","SSNC","ERIC","DUOL","DOX","ZM","KHC","Z","FER","INTC","ARGX","QQQ","USAW.SI","MKSI","CYBR","NBIX","JD","DASH","HTHT","MTCH","CG","ASML","TECH","STX","TSEM","PTC","RVMD","NTNX","ANSS","TSLA","ORLY","SAIA","LECO","PEP","CPRT","GRAB","LIN","MELI","WDC","MMYT","REGN","INTU","CTSH"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2503395625","title":"Vaxcyte, Inc.盘中异动 急速拉升5.23%报82.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503395625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503395625?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:37","pubTimestamp":1736951840,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时37分,Vaxcyte, Inc.股票出现异动,股价快速上涨5.23%。截至发稿,该股报82.23美元/股,成交量3.4104万股,换手率0.03%,振幅1.94%。Vaxcyte, Inc.股票所在的生物技术行业中,整体涨幅为0.71%。Vaxcyte, Inc.公司简介:Vaxcyte Inc 是一家疫苗公司,致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者,从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223720a2230008&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223720a2230008&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","PCVX","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502733084","title":"Vaxcyte, Inc.盘中异动 急速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502733084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502733084?lang=zh_cn&edition=full","pubTime":"2025-01-09 04:17","pubTimestamp":1736367466,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日04时17分,Vaxcyte, Inc.股票出现异动,股价大幅跳水5.02%。Vaxcyte, Inc.股票所在的生物技术行业中,整体涨幅为0.65%。其相关个股中,Sana Biotechnology, Inc.、Vir Biotechnology, Inc.、Silo Pharma, Inc.涨幅较大,Silo Pharma, Inc.、Hoth Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为3601.76%、848.34%、622.85%,振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为192.73%、156.87%、89.00%。Vaxcyte, Inc.公司简介:Vaxcyte Inc 是一家疫苗公司,致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者,从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010904174695fd3320&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010904174695fd3320&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","LU0053671581.USD","BK4139","PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494433755","title":"Vaxcyte, Inc.盘中异动 下午盘快速下跌5.01%报81.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494433755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494433755?lang=zh_cn&edition=full","pubTime":"2024-12-28 04:13","pubTimestamp":1735330425,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日04时13分,Vaxcyte, Inc.股票出现波动,股价快速下挫5.01%。截至发稿,该股报81.48美元/股,成交量40.3783万股,换手率0.32%,振幅4.25%。Vaxcyte, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Vaxcyte, Inc.公司简介:Vaxcyte Inc 是一家疫苗公司,致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者,从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228041345ab95330c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228041345ab95330c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX","BK4139","IE0009354923.USD","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492151849","title":"Vaxcyte, Inc.盘中异动 临近收盘快速跳水5.10%报85.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492151849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492151849?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:45","pubTimestamp":1734554714,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时45分,Vaxcyte, Inc.股票出现异动,股价急速下挫5.10%。截至发稿,该股报85.28美元/股,成交量67.579万股,换手率0.54%,振幅6.23%。Vaxcyte, Inc.股票所在的生物技术行业中,整体跌幅为3.05%。Vaxcyte, Inc.公司简介:Vaxcyte Inc 是一家疫苗公司,致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者,从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044514984cb920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219044514984cb920&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","IE0009354923.USD","PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485451114","title":"Vaxcyte, Inc.盘中异动 下午盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485451114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485451114?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:08","pubTimestamp":1732212530,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时08分,Vaxcyte, Inc.股票出现波动,股价急速拉升5.06%。截至发稿,该股报90.31美元/股,成交量87.3504万股,换手率0.70%,振幅5.69%。Vaxcyte, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。Vaxcyte, Inc.公司简介:Vaxcyte Inc 是一家疫苗公司,致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者,从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122020850971a7f07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122020850971a7f07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","BK4139","PCVX","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483388174","title":"Vaxcyte, Inc.涨0.89% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2483388174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483388174?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508282,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分,Vaxcyte, Inc.股票出现波动,股价大幅上涨0.89%。截至发稿,该股报100.26美元/股,成交量4199股,换手率0.00%,振幅0.00%。Vaxcyte, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。Vaxcyte, Inc.公司简介:Vaxcyte Inc 是一家疫苗公司,致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者,从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322312295be2318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322312295be2318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","PCVX","BK4139","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482427491","title":"Vaxcyte, Inc.2024财年第三财季实现净利润-1.03亿美元,同比减少11.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482427491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482427491?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:02","pubTimestamp":1731168124,"startTime":"0","endTime":"0","summary":"11月10日,Vaxcyte, Inc.公布财报,公告显示公司2024财年第三财季净利润为-1.03亿美元,同比减少11.16%;其中营业收入为0.00美元,每股基本收益为-0.83美元。从资产负债表来看,Vaxcyte, Inc.总负债1.42亿美元,其中短期债务9.64百万美元,资产负债比为25.08,流动比率为17.86。机构评级:截至2024年11月10日,当前有8家机构对Vaxcyte, Inc.目标价做出预测,其中目标均价为151.75美元,其中最低目标价为135.00美元,最高目标价为163.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000225a2278625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000225a2278625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479236716","title":"Vaxcyte, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479236716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2479236716?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:43","pubTimestamp":1730220190,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时43分,Vaxcyte, Inc.股票出现异动,股价大幅下跌5.26%。Vaxcyte, Inc.股票所在的生物技术行业中,整体跌幅为0.37%。Vaxcyte, Inc.公司简介:Vaxcyte Inc 是一家疫苗公司,致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者,从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000431198e3f27f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103000431198e3f27f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","PCVX","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vaxcyte.com","stockEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0828},{"period":"3month","weight":-0.0327},{"period":"6month","weight":-0.0325},{"period":"1year","weight":0.4074},{"period":"ytd","weight":0.2241}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vaxcyte, Inc.于2013年11月27日在特拉华州注册成立。该公司是一家下一代疫苗公司,旨在通过开发预防或治疗全球某些最常见和致命的传染病的新型疫苗来改善全球健康状况。他们的无细胞蛋白质合成平台使他们能够设计和生产蛋白质载体和抗原,这是疫苗的关键组成部分。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.007757},{"month":2,"riseRate":0.5,"avgChangeRate":0.015611},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.13682},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.015657},{"month":5,"riseRate":0.5,"avgChangeRate":0.041128},{"month":6,"riseRate":0.833333,"avgChangeRate":0.031665},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.000114},{"month":8,"riseRate":0.857143,"avgChangeRate":0.131285},{"month":9,"riseRate":0.428571,"avgChangeRate":0.06838},{"month":10,"riseRate":0.285714,"avgChangeRate":0.088587},{"month":11,"riseRate":0.5,"avgChangeRate":-0.025818},{"month":12,"riseRate":0.5,"avgChangeRate":0.007817}],"exchange":"NASDAQ","name":"Vaxcyte, Inc.","nameEN":"Vaxcyte, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vaxcyte, Inc.(PCVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vaxcyte, Inc.(PCVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vaxcyte, Inc.,PCVX,Vaxcyte, Inc.股票,Vaxcyte, Inc.股票老虎,Vaxcyte, Inc.股票老虎国际,Vaxcyte, Inc.行情,Vaxcyte, Inc.股票行情,Vaxcyte, Inc.股价,Vaxcyte, Inc.股市,Vaxcyte, Inc.股票价格,Vaxcyte, Inc.股票交易,Vaxcyte, Inc.股票购买,Vaxcyte, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vaxcyte, Inc.(PCVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vaxcyte, Inc.(PCVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}